Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

95
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
95
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

118
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
118
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

344
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
344

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond the Tip of the Iceberg: The Clinical Impact of Maternal Nonprimary Cytomegalovirus Infection.

The Pediatric infectious disease journal·2026
Same author

Physician adoption patterns of AI-driven clinical decision support systems in urinary tract infection management.

Scientific reports·2026
Same author

Correction: Fracture and mortality outcomes by osteoporosis treatment route in patients with type 2 diabetes and obesity: a propensity-matched registry study.

Frontiers in endocrinology·2026
Same author

Real-World Utilization of the HCV Care Cascade Before and After Implementation of a Program to Streamline Care and Promote Treatment.

Viruses·2026
Same author

Obesity in Late Adolescence and Healthcare Costs in Young to Mid-Adulthood.

Diabetes, obesity & metabolism·2026
Same author

Prevalence of Osteoporosis in Elderly Men: Large Real-World Data Addressing the Current Screening Evidence Gap.

Archives of osteoporosis·2026
Same journal

Lessons from extended induction and practical evidence for improving tofacitinib therapy in ulcerative colitis.

World journal of gastroenterology·2026
Same journal

Small animal <i>ex vivo</i> machine perfusion of the liver: A comprehensive literature review.

World journal of gastroenterology·2026
Same journal

Comparable remission and health care use in real-world inflammatory bowel disease patients initiating originator biologics <i>vs</i> biosimilars.

World journal of gastroenterology·2026
Same journal

Diagnosis and management of metabolic dysfunction-associated steatohepatitis in patients with chronic hepatitis B infection.

World journal of gastroenterology·2026
Same journal

Simultaneous treatment of concomitant achalasia coexisting with epiphrenic diverticulum: The practice of submucosal tunneling technique.

World journal of gastroenterology·2026
Same journal

Lianhe Xiaozhi ointment ameliorates metabolic dysfunction-associated steatotic liver disease <i>via</i> peroxisome proliferator-activated receptor alpha pathway activation.

World journal of gastroenterology·2026
See all related articles

Related Experiment Video

Updated: Dec 2, 2025

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI
06:09

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI

Published on: July 21, 2023

1.6K

Longitudinal decrease in platelet counts as a surrogate marker of liver fibrosis.

Neta Gotlieb1, Naama Schwartz2, Shira Zelber-Sagi1

  • 1Department of Gastroenterology and Hepatology, Tel-Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel.

World Journal of Gastroenterology
|November 2, 2020
PubMed
Summary
This summary is machine-generated.

A progressive decline in platelet counts (PTC), even within the normal range, can predict the future risk of developing liver cirrhosis. This early indicator, alongside rising fibrosis scores, aids in timely diagnosis of advanced liver disease.

Keywords:
CirrhosisCountPlateletsPredictionRangeTrend

More Related Videos

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
12:36

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

17.1K
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

53.9K

Related Experiment Videos

Last Updated: Dec 2, 2025

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI
06:09

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI

Published on: July 21, 2023

1.6K
Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
12:36

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

17.1K
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

53.9K

Area of Science:

  • Hepatology
  • Internal Medicine
  • Diagnostic Biomarkers

Background:

  • Liver cirrhosis poses a significant global health burden, often diagnosed late due to its asymptomatic early stages.
  • Early detection of advanced fibrosis is crucial, and non-invasive tools incorporating platelet counts are vital.
  • The association between longitudinal changes in normal-range platelet counts and cirrhosis risk remains under-explored.

Purpose of the Study:

  • To investigate if platelet count trajectories over time can predict advanced liver fibrosis across various liver disease etiologies.
  • To determine the predictive value of declining platelet counts within the normal range for cirrhosis development.

Main Methods:

  • A nested case-control study involving 5,258 cirrhosis cases and 15,744 controls matched for age and sex.
  • Analysis of longitudinal laboratory data, including platelet counts and liver enzymes, over 20 years preceding cirrhosis diagnosis.
  • Calculation and comparison of fibrosis scores (FIB-4, APRI) between cases and controls.

Main Results:

  • Cirrhosis cases showed a mean platelet count decrease from 240,000/μL to 190,000/μL up to 15 years before diagnosis, unlike stable controls.
  • This trend persisted across sexes and etiologies, being more pronounced in patients with complications like varices and ascites.
  • A decrease of 50 units in platelet count was associated with a 1.3 times increased odds of cirrhosis.

Conclusions:

  • A progressive decline in platelet counts, even within the normal range, precedes cirrhosis diagnosis.
  • This decline correlates with a gradual increase in liver fibrosis scores, highlighting its potential as an early predictive marker.
  • Longitudinal monitoring of platelet counts may offer a simple, non-invasive method for early risk assessment of advanced liver fibrosis.